Domestic price of Osimertinib

Osimertinib (Osimertinib) is a tyrosine kinase inhibitor used to treat non-small cell lung cancer that has been tested and found to have certain abnormalities in the epidermal growth factor receptor (EGFR) gene that has been approved by the U.S. Food and Drug Administration (FDA). Cancer (NSCLC), the most common side effects include low white blood cell count, low platelet count, diarrhea, low red blood cell count. Osimertinib may harm the developing fetus and women of reproductive potential are advised to use effective contraception during treatment and for six weeks after the last dose.

Osimertinib helps prevent recurrence of lung cancer in patients with EGFR exon 19 deletion or exon 21 L858R mutation after surgical removal of the tumor; or as a first-line treatment for patients with EGFR exon 19 deletion or exon 21 L858R mutation when the cancer has spread to other parts of the body (metastatic); or in patients with EGFR exon 19 deletion or exon 21 L858R mutation. In patients with the T790M mutation, when the lung cancer has spread to other parts of the body (metastatic) and previous treatments with EGFR tyrosine kinase inhibitor (TKI) drugs have not worked or no longer work.

OsimertinibThe original drug has been launched in China and has been covered by medical insurance. The price of 80mg*30 tablets per box may be around 5,000 yuan, which is relatively expensive. Currently available overseas Osimertinib generics, such as the specifications produced by Bangladesh Pharmaceutical FactoryThe price of each box of 80mg*30 tablets may be more than 800 yuan (the price may fluctuate due to exchange rate effects), which is relatively cheap. Osimertinib generics have basically the same pharmaceutical ingredients as the original drugs sold domestically and abroad. For more drug information and specific prices, please consult Yaode Medical Consultant.